APREA THERAPEUTICS INC (APRE) Top Institutional Shareholders
APREA THERAPEUTICS INC (APRE) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.71M in APRE holdings during the latest filing period.
Aigh Capital Management Llc is currently the largest disclosed institutional shareholder of APRE tracked by InsiderSet, reporting ownership valued at approximately $774,757 in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $791,918.872, representing an estimated gain of +2.22% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 96% of the total disclosed APRE value among the investors covered in this analysis. Major shareholders include Aigh Capital Management Llc, Vestal Point Capital, Lp, Sphera Funds Management Ltd., and several other long-term asset managers with concentrated positions in APREA THERAPEUTICS INC (APRE).
This page ranks the largest institutional APRE shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
22
Total Reported Value
$1.71M
Largest Holder
Aigh Capital Management Llc
Largest Position
$774,757
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
28
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Aigh Capital Management Llc | 0.16% | 1,015,541 | $774,757 | $791,919 | +$17,162 | +2.22% | |
| Vestal Point Capital, Lp | 0.01% | 350,000 | $267,015 | $272,930 | +$5,915 | +2.22% | |
| Sphera Funds Management Ltd. | 0.04% | 270,000 | $205,983 | $210,546 | +$4,563 | +2.22% | |
| Nantahala Capital Management, Llc | 0.01% | 205,760 | $156,974 | $160,452 | +$3,478 | +2.22% | |
| Geode Capital Management, Llc | 0.00% | 119,131 | $90,890 | $92,898 | +$2,008 | +2.21% | |
| Scientech Research Llc | 0.04% | 60,281 | $45,988 | $47,007 | +$1,019 | +2.22% | |
| Bnp Paribas Financial Markets | 0.00% | 39,817 | $30,376 | $31,049 | +$673 | +2.22% | |
| Vanguard Fiduciary Trust Co | 0.00% | 38,464 | $29,348 | $29,994 | +$646 | +2.20% | |
| Renaissance Technologies LLC | Jim Simons | 0.00% | 25,100 | $19,149 | $19,573 | +$424 | +2.21% |
| Morgan Stanley | 0.00% | 22,330 | $17,036 | $17,413 | +$377 | +2.21% | |
| Lpl Financial Llc | 0.00% | 21,052 | $16,061 | $16,416 | +$355 | +2.21% | |
| Vanguard Capital Management Llc | 0.00% | 19,622 | $14,972 | $15,301 | +$329 | +2.20% | |
| Hightower Advisors, Llc | 0.00% | 13,864 | $10,577 | $10,811 | +$234 | +2.21% | |
| Two Sigma Securities, Llc | 0.00% | 13,500 | $10,299 | $10,527 | +$228 | +2.22% | |
| Susquehanna International Group, Llp | 0.00% | 13,018 | $9,931 | $10,151 | +$220 | +2.22% | |
| Blackrock, Inc. | 0.00% | 8,504 | $6,487 | $6,631 | +$144 | +2.23% | |
| Tower Research Capital Llc (Trc) | 0.00% | 5,127 | $3,911 | $3,998 | +$87 | +2.23% | |
| Ubs Group Ag | 0.00% | 2,153 | $1,643 | $1,679 | +$36 | +2.19% | |
| Group One Trading Llc | 0.00% | 577 | $440 | $450 | +$10 | +2.26% | |
| Osaic Holdings, Inc. | 0.00% | 295 | $225 | $230 | +$5 | +2.24% | |
| Wealthcollab, Llc | 0.00% | 158 | $121 | $123 | +$2 | +1.83% | |
| Sbi Securities Co., Ltd. | 0.00% | 16 | $12 | $12 | +$0 | +3.97% |
Frequently asked questions about APRE
Who owns the most APRE stock?
The largest holders of APRE are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for APREA THERAPEUTICS INC (APRE).
Is APRE widely held by superinvestors?
Many widely followed stocks like APRE appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly APRE is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.